Factor VIIa (Systemic)

Brand Names : NovoSeven, coagulation factor VIIa (recombinant), eptacog alfa, factor 7, proconvertin, recombinant activated factor VIIa, recombinant coagulation factor VIIa, recombinant factor VIIa, rFVIIa.

Category

• Antihemorrhagic

Description

Factor VIIa is a man-made protein produced to replicate the naturally occurring activated factor VII (factor VIIa) in the body. Factor VIIa is used to stop bleeding of injuries for patients with hemophilia by helping the blood to clot. This man-made protein, factor VIIa, is used in people who have Hemophilia A or Hemophilia B, who have also formed antibodies against other clotting proteins that help bleeding to stop. Patients using factor VIIa are usually male.

Factor VIIa is to be administered only by or under the supervision of your doctor or other health care professional. It is available in the following dosage form(s):

Parenteral
• Injection (U.S.)

Brand Names

Some commonly used brand names are:

In the U.S. -

• NovoSeven

Other commonly used names are coagulation factor VIIa (recombinant) , eptacog alfa , factor 7 , proconvertin , recombinant activated factor VIIa , recombinant coagulation factor VIIa , recombinant factor VIIa , and rFVIIa.

† Not commercially available in Canada.